Corrigendum: Ex vivo modulation of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes

• Thomas Morgan Hulen,
• Christina Friese,
• Nikolaj Pagh Kristensen,
• Joachim Stoltenborg Granhøj,
• Troels Holz Borch,
• Marlies J. W. Peeters,
• Marco Donia,
• Mads Hald Andersen,
• Sine Reker Hadrup,
• Inge Marie Svane,
• Özcan Met,
• Özcan Met

Affiliations

Thomas Morgan Hulen

National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark

Christina Friese

National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark

Nikolaj Pagh Kristensen

Department of Health Technology, Technical University of Denmark, Lyngby, Denmark

Joachim Stoltenborg Granhøj

National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark

Troels Holz Borch

National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark

Marlies J. W. Peeters

National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark

Marco Donia

National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark

Mads Hald Andersen

National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark

Sine Reker Hadrup

Department of Health Technology, Technical University of Denmark, Lyngby, Denmark

Inge Marie Svane

National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark

Özcan Met

National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark

Özcan Met

Department of Health Technology, Technical University of Denmark, Lyngby, Denmark